You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
植耀輝: 美股震盪低收 港股27,000點料有支持
阿思達克 01-05 11:30
耀才證券研究部總監植耀輝稱,美股在今年首個交易日走勢波動,開市一度再創新高,但開市不久即掉頭向下,其後跌勢更進一步加劇,最多曾跌超過700點。其後走勢有所反彈,最終道指下跌382點或1.25%,收報30,223點,標普500指數亦跌55點或1.48%,收報3,700點,納指收報12,698點,下跌189點或1.47%。

至於港股,在2021年首個交易日造好,收報27,472點,上升241點,繼續逼近28,000點關口,成交金額亦達到1,826.4億元,當中更有10隻成份股創新高或一年以上新高。港股昨日能有好表現,A股造好及人民幣匯價急升皆屬主要原因,同時不少當炒板塊續見資金追捧,亦令市場氣氛持續升溫。由於強勢股仍見資金追捧(事實上,昨日單是友邦(01299.HK)及小米(01810.HK)便分別為大市貢獻105點及82點),相信恆指短期仍有機會再試高位,不過美股隔晚表現欠佳,或令大市升勢受阻,短線料繼續於27,000至28,000點水平上落。

至於股份方面,筆者今年重點推介之友邦及港交所(00388.HK)昨日表現相當不俗,仍可繼續持有,畢竟基本面仍然樂觀;另外,藥明生物(02269.HK)大股東又再度配股減持,相信股價或會受壓,不過此股過去反彈速度不弱,如今日(5日)股價見有支持,不妨作小注吸納並作中長線持有。

(筆者為證監會持牌人,持有港交所股份)~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account